Skip to content

Canceled by the investigator A randomized controlled trial for the efficacy and safety of preoperative respiratory exercise training for patients with moderate to high risk lung cancer

A single center, prospective, randomized controlled study on the efficacy and safety of preoperative respiratory exercise training in patients with moderate to high risk lung cancer

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000032397
Enrollment
Unknown
Registered
2020-04-27
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Control Group:none
Treatment Group:respiratory exercise training

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Any age of male and female; 2) Lung cancer confirmed by histology or cytology; 3) No systematic treatment or surgical treatment with lung cancer as indication has been received in the past; 4) Be able to understand and follow instructions, and be able to perform CPET physically; 5) Volunteer to participate in clinical research and sign informed consent; 6) Patients with 10ml/kg / min <ppo-vo2max <=20ml/kg/min after CPET screening.

Exclusion criteria

Exclusion criteria: 1) Paients that cannot cooperate with or have diseases that affect the results of CPET analysis: including (but not limited to) the history of syncope during exercise; unstable ischemic heart disease, NYHA class III / IV left ventricular failure, arrhythmia, uncontrolled hypertension, cerebrovascular disease, neuroskeletal muscle disease, serious metabolic disease and mental disease, uncontrolled thyroid function Hyperactivity, diabetes, severe depression, Alzheimer's disease; 2) Patients with respiratory tract infection within 4 weeks before screening or at screening stage. Patients can be screened again 4 weeks after the recovery of respiratory infection; 3) Patients with history of malignancies in any organ system in the past 5 years; 4) Patients with distant metastasis who are unable to perform surgery according to NCCN guideline 2019.

Design outcomes

Primary

MeasureTime frame
Perioperative mortality;Postoperative complications;

Secondary

MeasureTime frame
Cardiopulmonary exercise test;Pulmonary function;Borg Score;Arterial blood gas;

Countries

China

Contacts

Public ContactGuo Jian

Shanghai Pulmonary Hospital

jianjian11121978@163.com+86 13761023718

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026